Effect of S-adenosylmethionine tablets on the reduction of age-related mental decline in dogs: a double-blinded, placebo-controlled trial.

Oral S-adenosylmethionine (SAMe) tosylate supplementation (Novifit tablets, Virbac) was evaluated as a dietary aid for the management of age-related mental impairment in dogs. Thirty-six dogs older than 8 years that had displayed signs of cognitive dysfunction for at least 1 month were selected for the study. The dogs were administered 18 mg/kg SAMe tosylate (n=17) or identical placebo tablets (n=19) for 2 months. Concurrent behavioral treatment was forbidden. A 14-item standardized questionnaire evaluated behavior and locomotion difficulties. Compared with the placebo group, SAMe-treated dogs showed greater improvement in activity (41.7% versus 2.6% after 4 weeks, P<.0003; 57.1% versus 9.0% after 8 weeks, P<.003) and awareness (33.3% versus 17.9% after 4 weeks, P<.05; 59.5% versus 21.4% after 8 weeks, P<.01). The aggregate mental impairment score was reduced by more than 50% in 41.2% and 15.8% of dogs treated with SAMe and placebo, respectively, at week 8. SAMe tosylate tablets proved safe and effective in improving signs of age-related mental decline in dogs.

[1]  N. Milgram,et al.  Improvement of short-term memory performance in aged beagles by a nutraceutical supplement containing phosphatidylserine, Ginkgo biloba, vitamin E, and pyridoxine. , 2008, The Canadian veterinary journal = La revue veterinaire canadienne.

[2]  B. Saletu,et al.  Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry , 2005, European Neuropsychopharmacology.

[3]  J. Araujo,et al.  Behavior problems in geriatric pets. , 2005, The Veterinary clinics of North America. Small animal practice.

[4]  C. Cotman,et al.  Long-term treatment with antioxidants and a program of behavioral enrichment reduces age-dependent impairment in discrimination and reversal learning in beagle dogs , 2004, Experimental Gerontology.

[5]  F. Hoehler,et al.  S-Adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: A double-blind cross-over trial. [ISRCTN36233495] , 2004, BMC musculoskeletal disorders.

[6]  M. Fava,et al.  S-adenosyl-methionine in depression: A comprehensive review of the literature , 2003, Current psychiatry reports.

[7]  H. Semlitsch,et al.  Pharmacodynamic studies on the central mode of action of S-adenosyl-L-methionine (SAMe) infusions in elderly subjects, utilizing EEG mapping and psychometry , 2002, Journal of Neural Transmission.

[8]  Maurizio Fava,et al.  Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. , 2002, The American journal of clinical nutrition.

[9]  T. Bottiglieri.  S-Adenosyl-L-methionine (SAMe): from the bench to the bedside--molecular basis of a pleiotrophic molecule. , 2002, The American journal of clinical nutrition.

[10]  R. Delle Chiaie,et al.  Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies. , 2002, The American journal of clinical nutrition.

[11]  C. Cotman,et al.  Dietary enrichment counteracts age-associated cognitive dysfunction in canines , 2002, Neurobiology of Aging.

[12]  M. Nguyen,et al.  S-adenosylmethionine and depression. , 2002, Australian family physician.

[13]  B. Hart,et al.  Prevalence of behavioral changes associated with age-related cognitive impairment in dogs. , 2001, Journal of the American Veterinary Medical Association.

[14]  B. Hart,et al.  Predicting behavioral changes associated with age-related cognitive impairment in dogs. , 2001, Journal of the American Veterinary Medical Association.

[15]  I. Ferrer,et al.  Age-related Changes in the Brain of the Dog , 1999, Veterinary pathology.

[16]  S. Kish,et al.  Brain S‐Adenosylmethionine Levels Are Severely Decreased in Alzheimer's Disease , 1996, Journal of neurochemistry.

[17]  R. Torta,et al.  S-adenosyl-L-methionine normalizes P300 latency in patients with major depression: A preliminary report , 1994 .

[18]  F. Violante,et al.  Effects of S-adenosyl-L-methionine on cognitive and vigilance functions in the elderly , 1994 .

[19]  T. Bottiglieri,et al.  S‐adenosylmethionine levels in psychiatric and neurological disorders: a review , 1994, Acta neurologica Scandinavica. Supplementum.

[20]  G. M. Bressa,et al.  S‐adenosyl‐l‐methionine (SAMe) as antidepressant: meta‐analysis of clinical studies , 1994, Acta neurologica Scandinavica. Supplementum.

[21]  N. Milgram,et al.  Cognitive functions and aging in the dog: acquisition of nonspatial visual tasks , 1994 .

[22]  Brian J Cummings,et al.  β-Amyloid accumulation in aged canine brain: A model of early plaque formation in Alzheimer's disease , 1993, Neurobiology of Aging.

[23]  G. Muccioli,et al.  Effect of S-adenosyl-L-methionine on brain muscarinic receptors of aged rats. , 1992, European journal of pharmacology.

[24]  B. Toone,et al.  Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[25]  V. Voith,et al.  Behavioral problems in old dogs: 26 cases (1984-1987). , 1990, Journal of the American Veterinary Medical Association.

[26]  B. Cohen,et al.  Effects of the novel antidepressant S-adenosyl-methionine on α1- and β-adrenoceptors in rat brain , 1989 .

[27]  G. Muccioli,et al.  S-adenosyl-L-methionine restores prolactin receptors in the aged rabbit brain. , 1989, European journal of pharmacology.

[28]  M. Rubio,et al.  Acute effects of S-adenosyl-L-methionine on catecholaminergic central function. , 1989, European journal of pharmacology.

[29]  G. Stramentinoli,et al.  Pharmacologic aspects of S-adenosylmethionine. Pharmacokinetics and pharmacodynamics. , 1987, The American journal of medicine.

[30]  H. Barceló,et al.  Effect of S-adenosylmethionine on experimental osteoarthritis in rabbits. , 1987, The American journal of medicine.

[31]  B. König,et al.  A long-term (two years) clinical trial with S-adenosylmethionine for the treatment of osteoarthritis. , 1987, The American journal of medicine.

[32]  H. Müller-Fassbender.  Double-blind clinical trial of S-adenosylmethionine versus ibuprofen in the treatment of osteoarthritis. , 1987, The American journal of medicine.

[33]  G. Vantini,et al.  Age-related modification of dopaminergic and beta-Adrenergic receptor system: restoration to normal activity by modifying membrane fluidity with S-adenosylmethionine. , 1984, Life sciences.

[34]  J. Cline.  Canine cognitive dysfunction. , 2010 .

[35]  C. Cotman,et al.  Size and reversal learning in the beagle dog as a measure of executive function and inhibitory control in aging. , 2003, Learning & memory.

[36]  D. A. Gingerich,et al.  Use of client-specific outcome measures to assess treatment effects in geriatric, arthritic dogs: controlled clinical evaluation of a nutraceutical. , 2003, Veterinary therapeutics : research in applied veterinary medicine.

[37]  G. Saletu-Zyhlarz,et al.  Electrophysiological neuroimaging of the central effects of S-adenosyl-L-methionine by mapping of electroencephalograms and event-related potentials and low-resolution brain electromagnetic tomography. , 2002, The American journal of clinical nutrition.

[38]  I. Palacios,et al.  SAMe restores the changes in the proliferation and in the synthesis of fibronectin and proteoglycans induced by tumour necrosis factor alpha on cultured rabbit synovial cells. , 1997, British journal of rheumatology.

[39]  Brian J Cummings,et al.  Canine cognitive dysfunction as a model for human age-related cognitive decline, dementia and Alzheimer's disease: clinical presentation, cognitive testing, pathology and response to 1-deprenyl therapy. , 1995, Progress in brain research.

[40]  C. Di Padova,et al.  S-adenosylmethionine in the treatment of osteoarthritis. Review of the clinical studies. , 1987, The American journal of medicine.

[41]  S. Algeri,et al.  Changes in Rat Brain Noradrenaline and Serotonin Metabolism after Administration of S-Adenosylmethionine , 1979 .

[42]  S. Algeri,et al.  Effect of S-adenosyl-L-methionine on serotonin metabolism in rat brain. , 1978, Progress in neuro-psychopharmacology.